What is it about?
The study shows that oral treatment with Gene-Eden-VIR/Novirin completely clears the human papillomavirus (HPV) in infected individuals. Amazingly, after 12 months treatment, 100% of the participants were HPV free vs. only 53%, 52%, 65%, 20%, and 77% in the five control groups. In other words, within a year, Gene-Eden-VIR/Novirin completely eradicated the virus, while 23%-80% of the participants in the control groups still had the virus in their system.
Featured Image
Why is it important?
Currently, there are no oral treatments that get rid of the human papillomavirus (HPV). In other words, no drugs are available that clear the virus, or cure the infection. Vaccines are available for those uninfected by the virus. Infected individuals, who develop HPV warts, precancerous, or cancerous lesions, can remove the abnormal tissues with an operative procedure, such as cryotherapy, conization, or LEEP. This study presents Gene-Eden-VIR/Novirin as a possible alternative to being vaccinated or undergoing an operative procedure to remove HPV lesions.
Perspectives
"If you are considering being vaccinated against the HPV virus, or you are contemplating an operative procedure to remove HPV lesions, show our study to your doctor!"
Dr. Hanan Polansky
The Center for the Biology of Chronic Disease (CBCD)
Read the Original
This page is a summary of: Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus, Drug Design Development and Therapy, March 2017, Dove Medical Press,
DOI: 10.2147/dddt.s123340.
You can read the full text:
Contributors
The following have contributed to this page
